Sequana Medical NV
F:2SE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sequana Medical NV
F:2SE
|
BE |
|
S
|
SSR Mining Inc
LSE:0VGE
|
CA |
|
N
|
Nike Inc
XBER:NKE
|
US |
|
S
|
Sealed Air Corp
XBER:SDA
|
US |
|
TBS Holdings Inc
OTC:TKOBF
|
JP |
|
C
|
CNOOC Ltd
DUS:NC2B
|
CN |
|
Uber Technologies Inc
LSE:0A1U
|
US |
|
Reliance Global Group Inc
NASDAQ:RELI
|
US |
|
N
|
Nordic American Tanker Ltd
XBER:B3O
|
BM |
|
C
|
CapitaLand Integrated Commercial Trust
XMUN:M3T
|
SG |
|
Capitol Federal Financial Inc
NASDAQ:CFFN
|
US |
|
M
|
Microsoft Corp
MIL:1MSFT
|
US |
Sequana Medical NV
Sequana Medical makes implantable medical devices that help remove unwanted fluid from the body. Its best-known product is the alfapump, a small pump system that moves excess abdominal fluid out of the body in patients with severe liver disease and related fluid buildup. The company is also developing other treatments for fluid overload, including therapies aimed at heart failure patients. Its customers are mainly hospitals and specialist doctors who treat advanced liver and heart disease. Sequana Medical does not sell to patients directly; instead, its devices are used in clinical care settings and bought through hospital purchasing channels. The company makes money by selling its devices and, where applicable, related services and clinical use support. What makes Sequana Medical different is that it focuses on a very specific problem that medicines often do not solve well: chronic fluid overload. Rather than offering general hospital equipment, it targets a narrow group of patients with serious conditions where doctors need a more direct way to manage excess fluid and improve day-to-day comfort.
Sequana Medical makes implantable medical devices that help remove unwanted fluid from the body. Its best-known product is the alfapump, a small pump system that moves excess abdominal fluid out of the body in patients with severe liver disease and related fluid buildup. The company is also developing other treatments for fluid overload, including therapies aimed at heart failure patients.
Its customers are mainly hospitals and specialist doctors who treat advanced liver and heart disease. Sequana Medical does not sell to patients directly; instead, its devices are used in clinical care settings and bought through hospital purchasing channels. The company makes money by selling its devices and, where applicable, related services and clinical use support.
What makes Sequana Medical different is that it focuses on a very specific problem that medicines often do not solve well: chronic fluid overload. Rather than offering general hospital equipment, it targets a narrow group of patients with serious conditions where doctors need a more direct way to manage excess fluid and improve day-to-day comfort.
